Scapa Healthcare recently announced that it closed its 2020 fiscal year successfully, despite unprecedented global challenges. Throughout the year, the Scapa Healthcare team reportedly remained focused on executing its operational optimization plan; during the pandemic, the team demonstrated determination and adaptability while operating safely at all of its global locations to ensure uninterrupted supply chain to its customers. Notable highlights from the year include:

  • Response to COVID-19 pandemic
  • Consolidation of the Inglewood facility’s manufacturing equipment into the new built-for-purpose Knoxville site, allowing for greater operational efficiencies through proximity and scale
  • Enhancement of the Gargrave facility’s value proposition with the transfer of adhesive coating capabilities from Dunstable site
  • Two customer-driven technology transfers completed into the Knoxville facility to support additional product lines
  • Strong product pipeline across all market segments to support organic growth strategy

Looking ahead, Scapa Healthcare reports that it will continue to adapt to support the unprecedented high demand for medical products during the pandemic. The company anticipates increased demand for urgently needed products like hand sanitizers and advanced skin treatment solutions due to sanitization and skin-sensitivity concerns. Scapa Healthcare will continue to work in partnership with healthcare companies, leveraging its topical formulation capabilities and expertise to develop solutions to address evolving market needs.

In addition, Scapa Healthcare anticipates emerging supply chain concerns about medical and health care-related products coming from China to continue as a result of the COVID-19 pandemic. Global healthcare companies are looking to leverage vertically integrated companies to mitigate the risk of dealing with global supply chains with near-shore capabilities.

To continue to execute on its strategy, Scapa Healthcare has brought on a new management team led by John Petreanu, Scapa Healthcare’s new president. Under the new team’s leadership, Scapa Healthcare will reportedly remain focused on identifying new market trends and dynamics and react quickly to maximize emerging opportunities from the COVID-19 pandemic.

“Together with our peers and colleagues across the global community, we are proud of what we have been able to achieve during these unprecedented times, while prioritizing the safety of our employees and partners,” said Petreanu. “We continuously look to strengthen our value proposition as a leading outsource partner with a full range of services and remain focused on acquiring different technologies and solutions that enhance our capabilities and intellectual talent. Our goal is to continue delivering differentiated solutions to market faster and to give our customers a sustainable competitive advantage in the marketplace.”

For more information, visit